MYLAN LABS LTD FDA Approval ANDA 206053

ANDA 206053

MYLAN LABS LTD

FDA Drug Application

Application #206053

Application Sponsors

ANDA 206053MYLAN LABS LTD

Marketing Status

Prescription001

Application Products

001TABLET;ORAL0.02MG,0.15MG; 0.025MG,0.15MG;0.03MG,0.15MG; 0.01MG,N/A0LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOLETHINYL ESTRADIOL; LEVONORGESTREL

FDA Submissions

UNKNOWN; ORIG1AP2017-10-02STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAB

CDER Filings

MYLAN LABS LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 206053
            [companyName] => MYLAN LABS LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"LEVONORGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL","activeIngredients":"ETHINYL ESTRADIOL; LEVONORGESTREL","strength":"0.02MG,0.15MG; 0.025MG,0.15MG;0.03MG,0.15MG; 0.01MG,N\/A","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"10\/02\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2017-10-02
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.